Dermira

Dermira was a biopharmaceutical company focused on medical dermatology, developing and commercializing treatments for chronic skin conditions such as primary axillary hyperhidrosis (Qbrexza / glycopyrronium) and atopic dermatitis (lebrikizumab). Headquartered in Menlo Park, California and originally backed by venture investors including Canaan Partners, the company went public on NASDAQ (DERM) in 2014 and was acquired by Eli Lilly and Company in 2020. Its assets and operations are now part of Eli Lilly; the dermira.com domain redirects to lilly.com. Dermira did not operate a public developer program, API, or developer portal, so this profile carries company identity only and has no API artifacts to enrich.

Dermira is profiled on the APIs.io network. Tagged areas include Company, Biopharmaceutical, Pharmaceuticals, Dermatology, and Healthcare.

🌐 Visit website 📡 Source on GitHub

5.7/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-07-27 · rubric v0.5

0 APIs

CompanyBiopharmaceuticalPharmaceuticalsDermatologyHealthcareLife SciencesAcquired

Kin Score

Kin Score How this is scored →
scored 2026-07-27 · rubric v0.5

Composite quality — 5.7/100 · minimal

Contract Quality 0.0 / 25

Developer Ergonomics 0.0 / 20

Commercial Clarity 0.0 / 20

Operational Transparency 0.0 / 13

Governance 0.0 / 12

Discoverability 6.8 / 10

Agent readiness — 0/100 · human only

Machine-Readable Contract 0 / 18

Agentic Access Contract 0 / 15

MCP Server 0 / 12

Machine-Readable Auth 0 / 10

Idempotency 0 / 9

Stable Error Semantics 0 / 8

Request/Response Examples 0 / 7

Rate-Limit Signaling 0 / 7

Typed Event Surface 0 / 6

Agent Skills 0 / 5

Well-Known Catalog 0 / 4

Consent & Bot Identity 0 / 3

Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/dermira: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Source (apis.yml)

aid: dermira
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/dermira.png
name: Dermira
description: Dermira was a biopharmaceutical company focused on medical dermatology, developing and commercializing treatments
  for chronic skin conditions such as primary axillary hyperhidrosis (Qbrexza / glycopyrronium) and atopic dermatitis (lebrikizumab).
  Headquartered in Menlo Park, California and originally backed by venture investors including Canaan Partners, the company
  went public on NASDAQ (DERM) in 2014 and was acquired by Eli Lilly and Company in 2020. Its assets and operations are now
  part of Eli Lilly; the dermira.com domain redirects to lilly.com. Dermira did not operate a public developer program, API,
  or developer portal, so this profile carries company identity only and has no API artifacts to enrich.
url: https://raw.githubusercontent.com/api-evangelist/dermira/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- canaan-partners
x-tier: stub
x-tier-reason: portfolio-lead
x-status: acquired
x-acquired-by: eli-lilly
x-acquired-year: 2020
x-api-surface: none
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-18'
tags:
- Company
- Biopharmaceutical
- Pharmaceuticals
- Dermatology
- Healthcare
- Life Sciences
- Acquired
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
x-enrichment:
  date: '2026-07-19'
  status: backfilled
  pass: local-v1
  note: backfilled from .gitignore signal + verified work evidence